Patients with certain genetic profiles may tolerate semaglutide exceptionally well, while others benefit more from tirzepatide (which targets both GLP-1 and GIP receptors) or lower microdose protocols
Mention any history of gastrointestinal issues, pancreatitis, or thyroid disorders, as GLP-1 medications require special monitoring in these conditions
We have not yet seen any actual clinical trials of a GLP-1 RA for depression to help clear up their role here
Stevia and allulose were provided in drinking water, and each animal had access to 30 ml of sterile water daily with either 0.1 mL of stevia (sweetened to match allulose) or 3% allulose (to reach a daily dose of roughly 1.9 g/kg/day), as has been performed previously [12]
Clarke R, Sherliker P, Hin H, Molloy AM, Nexo E, Ueland PM, Emmens K, Scott JM, Evans JG